Inflammatory and clinical risk factors for asthma attacks (ORACLE2): a patient-level meta-analysis of control groups of 22 randomised trials
Fleur L. Meulmeester(Leiden University Medical Center), Simon Couillard(Université de Sherbrooke), Samuel Mailhot-Larouche(Université de Sherbrooke), Jacob K. Sont(Leiden University Medical Center), Jonathan Corren(California Allergy and Asthma Medical Group), Nicola A. Hanania(Baylor College of Medicine), Sanjay Ramakrishnan(Oxford BioMedica (United Kingdom)), Mario Castro(University of Kansas Medical Center), Timothy Hinks(University of Oxford), Emilio Santoro(GlaxoSmithKline (United Kingdom)), Michael E. Wechsler(National Jewish Health), A. Subhashini(Novartis (India)), Jo Hardy(North Bristol NHS Trust), Chris Compton(GlaxoSmithKline (United Kingdom)), Christopher E. Brightling(NIHR Leicester Biomedical Research Centre), Annette Laugerud, Richard Beasley(Medical Research Institute of New Zealand), Cécile Holweg(Roche (United States)), Sarah Diver(NIHR Leicester Biomedical Research Centre), David J. Jackson(Guy's Hospital), Ian Pavord(Oxford BioMedica (United Kingdom)), Samuel Lemaire‐Paquette(Centre Hospitalier Universitaire de Sherbrooke), Ewout W. Steyerberg(Erasmus MC), Megan E Hardin(Sanofi (United States)), Guy Brusselle(Ghent University Hospital), Neil Martin(NIHR Leicester Biomedical Research Centre), C.A. Celis-Preciado(Université de Sherbrooke)
Cited by 69
Related Papers
Assessing the Performance of Prediction Models
|Epidemiology|2009|4.9k
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal
|BMJ|2020|3.2k
Internal validation of predictive models
|Journal of Clinical Epidemiology|2001|2.6k
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
|New England Journal of Medicine|2018|1.9k
Towards better clinical prediction models: seven steps for development and an ABCD for validation
|European Heart Journal|2014|1.9k